Neurelis Raises $114M in Series D Financing

12 Mar, 2021

Neurelis Raises $114M in Series D Financing
Photo by AltumCode on Unsplash

– Neurelis, Inc. from San Diego develops novel therapies for epilepsy and other neurological disorders.
– The company closed $114m Series D financing round.
Cormorant Asset Management and Decheng Capital joined existing investors LYZZ Capital and HBM Healthcare Investments.
– In conjunction with this financing, Alexander Kwit has been appointed to the company’s Board of Directors.
– Kwit is a private investor who previously held the position of Executive Vice President of Royalty Pharma, a publicly traded company that buys royalty interests in biopharmaceutical products.

Biotechnology Health Care Medical North America Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: